Abbott Strikes Deal With FDA To Reopen Baby Formula Plant At Center Of National Shortage

The company said Monday that it had reached an agreement with the FDA to reopen its baby formula plant in Michigan, which had been closed due to safety concerns.

Once the FDA confirms that the plant is ready to reopen, it could resume production of baby formula within two weeks, after which it would take an additional six to eight weeks for products to hit store shelves, the company said in a statement.

Abbott said it will resume production of the formulas for babies with metabolic disorders, as well as other products.

Regulators launched an investigation into possible links between formula produced at the plant and a number of infant infections and two deaths.

The company said there was no link between Abbott formulas and the infections.

PLAY Forbes Business Full Screen About Connatix Read More Read More Read More Read More Read More Read More 1/1 Skip Ad Continue watching after the ad Visit Advertiser websiteGO TO PAGE

Baby Formula Shortage Worsened By Shopping Bots Buying Up Inventory.